Aquestive Therapeutics, Inc. logo AQST - Aquestive Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 10
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $9.00 DETAILS
HIGH: $12.00
LOW: $6.00
MEDIAN: $9.00
CONSENSUS: $9.00
UPSIDE: 118.45%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1
Revenue
Revenue 14.4 13.0 12.8 10.0 8.7 11.9 13.5 20.1 12.1 13.2 13.0 13.2 11.1 10.7 11.5 13.3 12.3 11.1 13.3 15.3 11.1 7.1 8.3 21.7 8.8 16.4 12.4 11.1 12.6 16.8 13.3 13.9 23.4 12.2 27.1 11.1 16.4
Cost of Revenue 3.5 5.8 4.5 4.6 3.7 4.5 4.4 4.5 4.4 4.7 4.8 6.6 4.7 5.3 4.6 5.2 4.2 3.4 4.4 4.5 2.8 2.8 3.0 3.5 3.7 6.8 4.6 5.4 3.5 4.8 5.6 5.0 5.6 5.6 4.9 5.1 4.2
Gross Profit 11.0 7.2 8.3 5.4 5.1 7.3 9.1 15.6 7.7 8.5 8.2 6.6 6.4 5.4 6.8 8.0 8.1 7.7 8.9 10.9 8.4 4.4 5.3 18.1 5.1 9.6 7.8 5.7 9.1 12.0 7.7 9.0 17.8 6.6 22.3 6.0 12.3
Operating Expenses
R&D Expenses 4.2 3.2 4.5 4.1 5.4 4.9 5.3 4.2 5.9 2.9 3.2 3.5 3.5 4.3 3.2 5.2 4.8 4.4 4.7 4.3 3.7 4.4 7.3 3.8 4.4 3.1 5.1 8.2 4.3 5.7 4.5 8.0 4.9 6.3 5.7 4.8 5.3
SG&A Expenses 11.0 32.8 15.2 12.7 19.1 16.0 12.1 11.4 10.7 9.6 7.4 7.4 7.5 11.8 12.5 15.6 13.0 15.0 12.1 13.1 13.2 15.6 11.8 13.9 14.6 16.5 13.7 16.2 17.9 18.7 12.3 33.6 7.6 7.6 6.2 5.2 6.1
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) (0.0) (0.0) 0.0 0 0 0 0
Operating Expenses 15.2 36.0 19.8 16.8 24.4 20.9 17.4 15.5 16.6 12.4 10.6 10.8 11.0 16.1 15.7 20.8 17.8 19.4 16.9 17.4 16.9 20.0 19.1 17.7 19.0 19.5 18.8 24.4 22.2 24.4 16.9 41.6 12.5 13.8 11.8 10.1 11.5
Operating Income
Operating Income (4.2) (28.8) (11.5) (11.4) (19.4) (13.6) (8.3) 0.1 (9.0) (3.9) (2.4) (4.2) (4.6) (10.7) (8.9) (12.8) (9.7) (11.7) (8.0) (6.5) (8.5) (15.6) (13.8) 0.4 (13.9) (9.9) (11.0) (18.7) (13.1) (12.3) (9.2) (32.7) 5.3 (7.3) 10.4 (4.1) 0.8
Interest Expense 3.9 4.3 4.3 4.3 4.3 4.2 4.2 4.2 4.2 3.2 1.3 1.4 1.5 1.7 3.7 3.6 3.5 3.6 6.6 6.2 6.1 4.7 2.8 2.7 2.8 2.8 2.7 1.9 1.9 1.9 1.9 1.9 1.9 2.0 2.0 1.9 1.8
Interest Income 0 0 0 0 0 0.7 1.0 1.4 0.3 0.2 1.5 0.1 14.5 0.1 0.0 0.0 0 0.1 0 0.4 0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.3 0.3 0.2 0 0.0 0 0 0 0
Profitability
EBITDA (4.1) (28.7) (11.3) (11.2) (19.2) (12.7) (7.2) 1.7 (8.4) (4.3) (0.6) (3.8) 9.9 (10.3) (8.3) (12.1) (9.0) (24.6) (7.2) (5.4) (7.8) (14.5) (13.1) 1.2 (12.9) (9.1) (15.0) (17.8) (12.0) (11.3) (12.4) (33.8) 7.0 (7.1) 11.4 (3.0) 1.7
EBIT (4.2) (28.8) (11.5) (11.4) (19.4) (12.8) (7.3) 1.4 (8.6) (4.8) (0.9) (4.1) 9.6 (10.6) (8.8) (12.7) (9.7) (25.4) (8.0) (6.1) (8.5) (15.6) (13.8) 0.4 (13.8) (9.8) (15.8) (18.5) (12.8) (12.0) (13.1) (34.6) 5.3 (8.1) 10.4 (3.9) 0.8
Income Before Tax (8.1) (31.9) (15.4) (13.5) (22.9) (17.1) (11.5) (2.7) (12.8) (8.0) (2.2) (5.5) 8.1 (12.4) (12.5) (16.3) (13.2) (28.9) (14.6) (12.4) (14.7) (20.4) (16.6) (2.3) (16.5) (12.6) (18.4) (20.5) (14.7) (13.9) (15.0) (36.5) 4.1 (10.0) 8.5 (5.9) (1.5)
Income Tax Expense 0 0 0 0 0 (0.0) 0 0 0 0.1 (0.1) 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0
Net Income (8.1) (31.9) (15.4) (13.5) (22.9) (17.1) (11.5) (2.7) (12.8) (8.1) (2.0) (5.8) 8.1 (12.4) (12.5) (16.3) (13.2) (28.9) (14.6) (12.4) (14.7) (20.4) (16.6) (2.3) (16.5) (12.6) (18.4) (20.5) (14.7) (13.9) (15.0) (36.5) 4.1 (10.0) 8.5 (5.9) (1.5)
Per Share Data
EPS (Basic) -0.07 -0.26 -0.14 -0.14 -0.24 -0.19 -0.13 -0.03 -0.17 -0.12 -0.03 -0.10 0.35 -0.33 -0.23 -0.44 -0.40 -0.72 -0.37 -0.33 -0.41 -0.60 -0.49 -0.07 -0.49 -0.48 -0.74 -0.82 -0.59 -0.56 -0.64 -1.52 0.20 -0.50 0.39 -0.29 -0.07
EPS (Diluted) -0.07 -0.26 -0.14 -0.14 -0.24 -0.19 -0.13 -0.03 -0.17 -0.12 -0.03 -0.10 0.26 -0.33 -0.23 -0.44 -0.40 -0.72 -0.37 -0.33 -0.41 -0.60 -0.49 -0.07 -0.49 -0.48 -0.74 -0.82 -0.59 -0.56 -0.64 -1.52 0.20 -0.50 0.39 -0.29 -0.07
Shares Outstanding 122.6 122.0 110.6 99.3 95.5 91.2 91.1 90.9 73.6 68.5 64.7 57.4 55.6 54.4 53.4 45.3 41.3 40.4 39.2 37.1 35.6 33.8 33.6 33.6 33.6 26.4 25.0 25.0 25.0 24.9 23.6 24 20 20 20 20 20
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q1
Current Assets
Cash & Cash Equivalents 110.7 121.2 129.1 60.5 68.7 71.5 77.9 89.9 95.2 23.9 24.9 22.4 26.9 27.3 18.6 17.7 14.7 28.0 31.2 34.2 27.5 31.8 17.1 25.4 35.5 49.3 20.9 22.2 39.9 60.6 64.0 10.6 16.5 17.4 (9.2)
Short-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4
Net Receivables 6.9 17.8 11.8 11.9 10.4 7.3 9.7 6.0 8.3 8.5 8.6 10.1 7.6 4.7 10.7 19.2 19.9 12.1 13.6 12.1 10.2 7.0 8.0 12.9 9.5 13.1 10.3 10.2 7.5 6.5 7.5 6.6 9.4 6.2 0
Inventory 8.1 6.2 7.9 8.1 7.2 6.0 7.0 7.0 7.7 6.8 7.1 6.0 7.0 5.8 6.7 5.0 4.6 4.0 2.9 2.8 2.8 2.5 3.2 3.2 3.1 2.9 4.1 4.6 5.1 5.4 4.5 4.3 3.9 4.0 0
Other Current Assets 4.5 4.2 2.9 1.2 2.9 3.3 2.0 1.2 2.1 1.9 1.9 1.3 2.3 2.1 0 0 0 0 0 0 0 0 0 0 0 0 2.7 2.1 3.4 1.7 1.4 5.0 0.0 0 0
Total Current Assets 130.2 149.3 151.7 81.7 89.2 88.2 96.6 104.0 113.4 41.0 42.5 39.8 43.7 39.9 38.1 43.5 42.6 47.3 50.2 51.0 44.4 44.6 31.7 43.9 51.1 68.3 38.1 39.1 56.0 74.2 77.4 26.6 30.4 28.2 9.2
Non-Current Assets
Property, Plant & Equipment 8.3 8.5 8.7 8.8 8.8 9.0 9.2 9.4 9.5 9.7 10.2 10.4 9.7 9.3 6.4 6.9 7.0 7.8 8.1 8.9 9.6 10.3 11.3 12.2 13.0 9.7 10.4 10.9 11.6 12.2 12.2 12.8 12.8 13.5 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 1.2 1.3 1.3 1.4 1.4 1.4 1.5 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0
Long-Term Investments 2 2 2 0 3 3 3 0 0 4 0 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0 0
Other Non-Current Assets 0.6 0.6 1.2 3.2 1.2 1.2 1.2 4.2 5.4 1.4 5.5 5.5 6.5 6.5 5.9 5.9 6.9 6.9 6.9 6.9 7.8 7.8 7.3 7.3 0.3 0 0.2 0.2 0.2 0.2 0.2 0.2 2.7 1.2 (9.2)
Total Non-Current Assets 10.9 11.2 11.9 12.0 13.1 13.2 13.4 13.6 16.1 16.5 17.0 17.2 17.6 17.2 13.8 12.8 13.9 14.7 15.1 15.9 17.5 18.3 18.7 19.6 13.4 10.2 10.8 11.3 12.0 12.7 12.7 13.2 15.7 15.0 (9.2)
Total Assets 141.1 160.4 163.6 93.7 102.2 101.4 110.0 117.6 129.5 57.4 59.4 57.0 61.3 57.1 51.8 56.3 56.5 62.0 65.3 66.9 61.9 62.9 50.4 63.5 64.5 78.5 48.8 50.4 68.0 86.9 90.0 39.8 46.1 43.1 0
Current Liabilities
Account Payables 11.9 29.9 10.9 12.0 12.3 10.3 7.6 5.7 10.5 8.9 10.0 10.7 12.4 9.9 11.1 8.9 8.5 8.3 6.2 8.1 6.7 7.1 9.2 8.8 10.3 12.3 14.2 20.0 19.1 20.4 12.3 16.5 11.0 9.6 0
Short-Term Debt 15.3 11.6 8.5 3.2 0.0 0.0 0.0 0.0 0.0 0.0 4.6 18.4 17.2 18.7 14.2 9.8 6.6 2.0 7.7 5.2 3.9 2.6 1.8 0 0 0 0 0.6 6.8 4.6 2.8 1.1 1.6 0 0
Deferred Revenue 1.1 1.1 1.1 1.1 1.0 1.0 1.0 1.0 1.6 1.6 2.6 4.0 4.8 1.5 0.8 1.6 1.6 0.8 0.8 0.6 0.4 0.7 0.7 0.8 0.7 0.8 0.8 0.6 0.7 0.7 0.8 1.2 1.2 1.3 0
Other Current Liabilities 1.4 5.0 1.4 4.9 3.3 1 4.5 3.7 2.6 5.1 3.8 3.8 3.6 7.5 6.8 5.4 3.3 7.2 6.4 5.8 5.6 7.8 4.1 3.0 1.9 1.7 1.5 1.2 1.2 3.6 5.2 2.3 0 0.6 0
Total Current Liabilities 31.8 47.6 25.6 23.2 18.3 18.9 15.2 13.9 18.1 18.3 24.1 38.7 40.4 39.5 36.6 29.6 24.2 22.0 25.0 23.0 20.1 21.1 18.4 14.9 15.4 18.6 20.1 24.6 29.6 33.0 21.3 23.5 23.5 15.3 0
Non-Current Liabilities
Long-Term Debt 114.1 115.5 115.9 31.8 33.7 32.5 31.3 30.0 28.8 27.5 34.6 20.8 25.2 33.4 38.7 43.8 47.7 51.6 32.7 34.1 34.2 34.3 60.3 61.5 60.9 60.3 59.8 46.9 40.7 42.6 44.1 45.3 44.3 45.5 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 59.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 6.1 7.3 2.1 86.7 86.6 85.2 83.6 82.2 81.8 80.3 65.5 65.5 66.2 66.1 65.5 64.2 62.2 2.5 58.4 54.8 52.1 49.5 1.5 1.4 1.4 1.4 1.3 1.3 1.2 1.2 1.2 10.0 1.1 8.8 0
Total Non-Current Liabilities 143.4 146.5 142.1 143.1 144.9 142.7 140.2 139.2 147.8 145.6 138.3 125.0 130.1 136.1 123.1 123.0 125.5 122.2 100.6 97.6 93.7 90.3 68.6 70.1 70.0 66.0 63.2 50.4 44.4 43.8 45.2 55.3 45.4 54.3 0
Total Liabilities 175.2 194.1 167.7 166.3 163.2 161.6 155.4 153.1 165.8 163.9 162.4 163.6 170.5 175.6 159.7 152.7 149.7 144.1 125.6 120.6 113.7 111.4 86.9 84.9 85.3 84.6 83.3 75.1 74.0 76.8 66.6 78.8 68.9 69.6 0
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0
Retained Earnings (455.1) (447.0) (415.1) (399.7) (386.1) (363.2) (346.2) (334.6) (331.9) (319.1) (311.0) (308.9) (303.1) (311.2) (298.9) (286.3) (270.0) (256.8) (227.9) (213.3) (200.9) (186.3) (165.9) (149.3) (147.0) (130.5) (117.8) (99.4) (79.0) (61.4) (47.4) (32.4) (23.2) (120.1) 0
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (37.3) (36.6) (35.9) (35.2) (34.4) (33.7) (32.9) (32.0) (96.0)
Total Stockholders' Equity (34.1) (33.7) (4.1) (72.6) (60.9) (60.2) (45.4) (35.5) (36.3) (106.5) (102.9) (106.7) (109.2) (118.6) (107.8) (96.4) (93.1) (82.1) (60.3) (53.8) (51.8) (48.5) (36.5) (21.4) (20.8) (6.1) (34.5) (24.7) (6.1) 10.1 23.4 (38.9) (22.8) (26.5) (17.6)
Total Liabilities & Equity 141.1 160.4 163.6 93.7 102.2 101.4 110.0 117.6 129.5 57.4 59.4 57.0 61.3 57.1 51.8 56.3 56.5 62.0 65.3 66.9 61.9 62.9 50.4 63.5 64.5 78.5 48.8 50.4 68.0 86.9 90.0 39.8 46.1 43.1 (17.6)
Debt Metrics
Total Debt 133.6 131.4 128.9 40.3 39.1 38.0 36.9 35.7 34.5 33.3 45.0 45.1 48.4 57.5 55.1 56.0 56.9 56.4 43.4 42.5 41.5 40.5 65.8 65.4 65.0 60.3 59.8 47.4 47.6 47.2 46.8 46.4 46.0 45.5 0
Net Debt 22.8 10.3 (0.2) (20.3) (29.5) (33.5) (41.0) (54.1) (60.7) 9.4 20.1 22.7 21.5 30.2 36.4 38.3 42.1 28.4 12.3 8.2 14.0 8.7 48.7 40.0 29.4 11.0 38.9 25.3 7.7 (13.4) (17.2) 35.8 29.5 28.1 9.2
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1
Operating Activities
Net Income (8.1) (31.9) (15.4) (13.5) (22.9) (17.1) (11.5) (2.7) (12.8) (8.1) (2.0) (5.8) 8.1 (12.4) (12.5) (16.3) (13.2) (28.9) (14.6) (12.4) (14.7) (20.4) (16.6) (2.3) (16.5) (12.6) (18.4) (20.5) (14.7) (13.9) (15.0) (36.5) 4.1 (10.0) 8.5 (5.9) (1.5)
Depreciation & Amortization 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.5 0.3 0.3 0.3 0.4 0.6 0.7 0.7 0.7 0.7 0.7 0.8 1.3 1.2 1.4 1.5 0.8 0.7 0.7 0.7 0.8 0.7 0.8 1.0 1.0 1.0 0.9 0.9
Stock-Based Compensation 0 1.4 2.8 1.9 1.6 2.4 1.6 1.5 1.6 0.9 0.8 0.6 0.3 0.7 0.5 2.2 0.9 1.7 1.9 1.7 1.5 0 1.8 1.8 1.9 0 1.9 1.8 1.5 1.4 1.2 27.3 0 0 0 0 0
Change in Working Capital (12.4) 19.1 (2.9) 0.9 (5.0) 5.3 (4.8) (8.4) (2.0) (1.1) (1.4) (3.1) 0.3 19.7 12.0 5.0 (4.7) 2.8 (2.0) 3.8 (6.3) 1.3 4.0 (9.9) 3.6 (1.3) (4) 0.3 (6.1) 8.5 (2.9) 6.6 (4.1) 0.3 5.7 (1.7) 3.6
Other Non-Cash Items 5.5 2.8 2.8 2.7 2.8 2.7 2.7 2.4 2.7 5.4 0.1 0.1 (0.2) (0.1) 2.2 1.9 1.8 15.7 4.8 4.3 4.7 4.3 1.2 (0.9) (4.0) 2.6 0.1 0.4 0.9 0.5 0.4 29.7 (0.2) 1.3 0.5 0.4 0.9
Operating Cash Flow (14.8) (8.5) (12.6) (7.9) (23.4) (6.5) (11.9) (7.0) (10.4) (4.9) (2.3) (7.9) 8.8 8.4 2.8 (6.6) (14.5) (8.1) (9.1) (1.8) (14.1) (13.5) (8.3) (10.0) (13.6) (10.6) (14.8) (17.2) (17.7) (2.8) (11.5) 0.5 0.8 (7.4) 15.6 (6.3) 3.9
Investing Activities
Capital Expenditure (0.1) (0.1) (0.2) (0.1) (0.1) (0.0) (0.1) (0.0) (0.0) (0.0) (0.2) (0.8) (0.0) (0.0) (1.7) (0.7) (0.1) (0.5) (0.1) (0.2) (0.1) (0.2) (0.0) (0.1) (0.1) (0.1) (0.1) (0.1) (0.4) (0.5) (0.4) (0.6) (0.3) (0.1) (0.4) (0.9) (0.7)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.5) 0 0 0 0 0 0 0
Investing Cash Flow (0.1) (0.1) (0.2) (0.1) (0.1) (0.0) (0.1) (0.0) (0.0) (0.0) (0.2) (0.8) (0.0) (0.0) (1.7) (0.7) (0.1) (0.5) (0.1) (0.2) (0.1) (0.2) (0.0) (0.1) (0.1) (0.1) (0.1) (0.1) (0.4) (0.5) (0.4) (0.6) (0.3) (0.1) (0.4) (0.9) (0.7)
Financing Activities
Net Debt Issuance (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (39.0) 1.0 (4.5) (9.1) (0.7) 0.7 (0.7) 0 0 0 0 0 22.3 0 0 0 (0.0) 17.6 0 0 0 0 0 0 0 0 0 5
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) (0.1) (0.0) 0 (0.1) 0 (2.6) 0 (0.3) (5.6) 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (0.3) (0.0) 1.7 0.0 (0.7) 0.2 (0.2) 0.0 (0.4) 39.3 3.8 4.6 (1.0) (5.9) (1.4) 5.9 0 0.3 (0.0) 0.1 0 (0.0) 0 0.1 0 (0.1) (4.0) (0.5) (2.6) (0.2) 65.3 (5.7) (1.4) (0.6) (0.0) (0.0) 0.0
Financing Cash Flow 4.4 0.7 81.4 (0.1) 20.6 0.2 (0.0) 1.7 81.7 3.9 5.0 4.3 (9.2) 0.2 (0.1) 10.2 1.3 5.5 6.1 8.7 9.9 28.5 (0.0) 0.0 (0.0) 39.1 13.6 (0.5) (2.6) (0.1) 65.3 (5.7) (1.4) (0.6) (0.0) (0.0) 5.0
Cash Position
Net Change in Cash (10.4) (7.9) 68.5 (8.1) (2.9) (6.3) (12.0) (5.3) 71.3 (1.0) 2.5 (4.4) (0.4) 8.6 1.0 3.0 (13.3) (3.1) (3.1) 6.7 (4.3) 14.7 (8.4) (10.1) (13.8) 28.4 (1.3) (17.8) (20.7) (3.4) 53.3 (5.8) (0.9) (8.1) 15.2 (7.2) 8.3
Cash at Beginning 121.2 129.1 60.5 68.7 71.5 77.9 89.9 95.2 23.9 24.9 22.4 26.9 27.3 18.6 17.7 14.7 28.0 31.2 34.2 27.5 31.8 17.1 25.4 35.5 49.3 20.9 22.2 39.9 60.6 64.0 10.6 16.5 17.4 25.4 10.3 17.5 9.2
Cash at End 110.7 121.2 129.1 60.5 68.7 71.5 77.9 89.9 95.2 23.9 24.9 22.4 26.9 27.3 18.6 17.7 14.7 28.0 31.2 34.2 27.5 31.8 17.1 25.4 35.5 49.3 20.9 22.2 39.9 60.6 64.0 10.6 16.5 17.4 25.4 10.3 17.5
Free Cash Flow (14.9) (8.6) (12.9) (8.0) (23.5) (6.5) (12.0) (7.0) (10.4) (5.0) (2.5) (8.7) 8.8 8.4 1.1 (7.2) (14.6) (8.6) (9.1) (1.9) (14.2) (13.7) (8.4) (10.1) (13.8) (10.7) (14.9) (17.3) (18.1) (3.3) (11.9) (0.1) 0.5 (7.5) 15.2 (7.2) 3.3
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1
Income Statement
Revenue 14.4 13.0 12.8 10.0 8.7 11.9 13.5 20.1 12.1 13.2 13.0 13.2 11.1 10.7 11.5 13.3 12.3 11.1 13.3 15.3 11.1 7.1 8.3 21.7 8.8 16.4 12.4 11.1 12.6 16.8 13.3 13.9 23.4 12.2 27.1 11.1 16.4
Gross Profit 11.0 7.2 8.3 5.4 5.1 7.3 9.1 15.6 7.7 8.5 8.2 6.6 6.4 5.4 6.8 8.0 8.1 7.7 8.9 10.9 8.4 4.4 5.3 18.1 5.1 9.6 7.8 5.7 9.1 12.0 7.7 9.0 17.8 6.6 22.3 6.0 12.3
Operating Income (4.2) (28.8) (11.5) (11.4) (19.4) (13.6) (8.3) 0.1 (9.0) (3.9) (2.4) (4.2) (4.6) (10.7) (8.9) (12.8) (9.7) (11.7) (8.0) (6.5) (8.5) (15.6) (13.8) 0.4 (13.9) (9.9) (11.0) (18.7) (13.1) (12.3) (9.2) (32.7) 5.3 (7.3) 10.4 (4.1) 0.8
Net Income (8.1) (31.9) (15.4) (13.5) (22.9) (17.1) (11.5) (2.7) (12.8) (8.1) (2.0) (5.8) 8.1 (12.4) (12.5) (16.3) (13.2) (28.9) (14.6) (12.4) (14.7) (20.4) (16.6) (2.3) (16.5) (12.6) (18.4) (20.5) (14.7) (13.9) (15.0) (36.5) 4.1 (10.0) 8.5 (5.9) (1.5)
EPS (Diluted) -0.07 -0.26 -0.14 -0.14 -0.24 -0.19 -0.13 -0.03 -0.17 -0.12 -0.03 -0.10 0.26 -0.33 -0.23 -0.44 -0.40 -0.72 -0.37 -0.33 -0.41 -0.60 -0.49 -0.07 -0.49 -0.48 -0.74 -0.82 -0.59 -0.56 -0.64 -1.52 0.20 -0.50 0.39 -0.29 -0.07
Balance Sheet
Cash & Equivalents 110.7 121.2 129.1 60.5 68.7 71.5 77.9 89.9 95.2 23.9 24.9 22.4 26.9 27.3 18.6 17.7 14.7 28.0 31.2 34.2 27.5 31.8 17.1 25.4 35.5 49.3 20.9 22.2 39.9 60.6 64.0 10.6 16.5 17.4 (9.2)
Total Assets 141.1 160.4 163.6 93.7 102.2 101.4 110.0 117.6 129.5 57.4 59.4 57.0 61.3 57.1 51.8 56.3 56.5 62.0 65.3 66.9 61.9 62.9 50.4 63.5 64.5 78.5 48.8 50.4 68.0 86.9 90.0 39.8 46.1 43.1 0
Total Debt 133.6 131.4 128.9 40.3 39.1 38.0 36.9 35.7 34.5 33.3 45.0 45.1 48.4 57.5 55.1 56.0 56.9 56.4 43.4 42.5 41.5 40.5 65.8 65.4 65.0 60.3 59.8 47.4 47.6 47.2 46.8 46.4 46.0 45.5 0
Stockholders' Equity (34.1) (33.7) (4.1) (72.6) (60.9) (60.2) (45.4) (35.5) (36.3) (106.5) (102.9) (106.7) (109.2) (118.6) (107.8) (96.4) (93.1) (82.1) (60.3) (53.8) (51.8) (48.5) (36.5) (21.4) (20.8) (6.1) (34.5) (24.7) (6.1) 10.1 23.4 (38.9) (22.8) (26.5) (17.6)
Cash Flow
Operating Cash Flow (14.8) (8.5) (12.6) (7.9) (23.4) (6.5) (11.9) (7.0) (10.4) (4.9) (2.3) (7.9) 8.8 8.4 2.8 (6.6) (14.5) (8.1) (9.1) (1.8) (14.1) (13.5) (8.3) (10.0) (13.6) (10.6) (14.8) (17.2) (17.7) (2.8) (11.5) 0.5 0.8 (7.4) 15.6 (6.3) 3.9
Capital Expenditure (0.1) (0.1) (0.2) (0.1) (0.1) (0.0) (0.1) (0.0) (0.0) (0.0) (0.2) (0.8) (0.0) (0.0) (1.7) (0.7) (0.1) (0.5) (0.1) (0.2) (0.1) (0.2) (0.0) (0.1) (0.1) (0.1) (0.1) (0.1) (0.4) (0.5) (0.4) (0.6) (0.3) (0.1) (0.4) (0.9) (0.7)
Free Cash Flow (14.9) (8.6) (12.9) (8.0) (23.5) (6.5) (12.0) (7.0) (10.4) (5.0) (2.5) (8.7) 8.8 8.4 1.1 (7.2) (14.6) (8.6) (9.1) (1.9) (14.2) (13.7) (8.4) (10.1) (13.8) (10.7) (14.9) (17.3) (18.1) (3.3) (11.9) (0.1) 0.5 (7.5) 15.2 (7.2) 3.3